The fertility-sparing treatment in patients with endometrial atypical hyperplasia and early endometrial cancer: A debated therapeutic option

References

• Amant F, Moerman P, Neven P, Timmerman D, Van Limbergen E, Vergote I. Endometrial cancer. Lancet 2005; 366: 491–505
   PubMed Web of Science ®Google Scholar
• Gallup D G, Stock R J. Adenocarcinoma of the endometrium in women 40 years of age or younger. Obstet Gynecol 1984; 64: 417–420
   PubMed Web of Science ®Google Scholar
• Sherman M E. Theories of endometrial carcinogenesis: a multidisciplinary approach. Mod Pathol 2001; 13: 295–308
   Google Scholar
• Benshushan A. Endometrial adenocarcinoma in young patients: evaluation and fertility-preserving treatment. Eur J Obstet Gynecol Reprod Biol 2004; 117: 132–137
   Google Scholar
• Rackow B W, Arici A. Endometrial cancer and fertility. Curr Opin Obstet Gynecol 2006; 18: 245–252
   Google Scholar
• Creasman W T, Odicino F, Maisonneuve P, Quinn M A, Beller U, Heintz A PM, Nyan H YS, Pecorelli S. Carcinoma of the corpus uteri. Int J Gynecol Obstet 2006; 95(Suppl 1)S105–S143
   PubMedGoogle Scholar
• Ota T, Yoshida M, Kimura M, Kinoshita K. Clinicopathologic study of uterine endometrial carcinoma in young women aged 40 years and younger. Int J Gynecol Cancer 2005; 15: 657–662
   PubMed Web of Science ®Google Scholar
• Crissman J D, Azoury R S, Barnes A E, Schellhas H F. Endometrial carcinoma in women 40 years of age or younger. Obstet Gynecol 1981; 57: 699–704
   PubMed Web of Science ®Google Scholar
• Evans-Metcalf E R, Brooks S E, Reale F R, Baker S P. Profile of women 45 years of age and younger with endometrial cancer. Obstet Gynecol 1998; 91: 349–354
   PubMed Web of Science ®Google Scholar
• Ramirez P T, Frumovitz M, Bodurka D C, Sun C C, Levenback C. Hormonal therapy for the management of grade 1 endometrial adenocarcinoma: a literature review. Gynecol Oncol 2004; 95: 133–138
   PubMed Web of Science ®Google Scholar
• Kaku T, Matsuo K, Tsukamoto N, Shimamoto T, Sugihara K, Tsuruchi N, To N, Kamura T, Saito T, Imachi M, et al. Endometrial carcinoma in women aged 40 years or younger: a Japanese experience. Int J Gynecol Cancer 1993; 3: 147–153
   Google Scholar
• Patsner B. Endometrial cancer in women 45 years of age or younger. Eur J Gynaecol Oncol 2000; 21: 249–250
   PubMed Web of Science ®Google Scholar
• Boronow R C. Surgical staging of endometrial cancer: evolution, evaluation, and responsible challenge – a personal perspective. Gynecol Oncol 1997; 66: 179–189
   PubMed Web of Science ®Google Scholar
• Brémond A, Bataillard A, Thomas L, Achard J L, Fervers B, Fondrinier E, Lansac J, Bailly C, Hoffstetter S, Basuyau J P, et al. Standards, options and recommendations for the surgical management of carcinoma of the endometrium. Bull Cancer 2001; 88: 181–198
   Google Scholar
• Gadducci A, Cosio S, Genazzani A R. Treatment planning in endometrial cancer. Cancer Therapy 2003; 1: 373–391
   Google Scholar
• Watanabe Y, Aoki D, Kitagawa R, Takeuchi S, Sagae S, Sakuragi N, Yaegashi N. Disease Committee of Uterine Endometrial Cancer, Japanese Gynecologic Oncology Group. Status of surgical treatment procedures for endometrial cancer in Japan: results of a Japanese Gynecologic Oncology Group survey. Gynecol Oncol 2007; 105: 325–328
   Google Scholar
• Leitao M M. Current and future surgical approaches in the management of endometrial carcinoma. Future Oncol 2008; 4: 389–401
   PubMed Web of Science ®Google Scholar
• Fiorelli J L, Herzog T J, Wright J D. Current treatment strategies for endometrial cancer. Expert Rev Anticancer Ther 2008; 8: 1149–1157
   PubMed Web of Science ®Google Scholar
• Tozzi R, Malur S, Koehler C, Schneider A. Laparoscopy versus laparotomy in endometrial cancer: first analysis of survival of a randomized prospective study. J Minim Invasive Gynecol 2005; 12: 130–136
   PubMed Web of Science ®Google Scholar
• Reynolds R K, Burke W M, Advincula A P. Preliminary experience with robot-assisted laparoscopic staging of gynecologic malignancies. J Soc Laparoendosc Surg 2005; 9: 149–158
   PubMedGoogle Scholar
• Walker J L, Piedmonte M, Spirtos N, Eisenkop S, Schlaerth J, Mannel R S, Spiegel G. Surgical staging of uterine cancer: randomized phase III trial of laparoscopy vs. laparotomy – a Gynecologic Oncology Group Study (GOG): preliminary results. J Clin Oncol 2006, (ASCO Annual Meeting Proceedings Part I) 24:No. 18S (June 20 Suppl):5010
   Google Scholar
• Janda M, Gebski V, Forder P, Jackson D, Williams G, Obermair A. LACE Trial Committee. Total laparoscopic versus open surgery for stage 1 endometrial cancer: the LACE randomized controlled trial. Contemp Clin Trials 2006; 27: 353–363
   Google Scholar
• Magrina J F. Robotic surgery in gynecology. Eur J Gynaecol Oncol 2007; 28: 77–82
   Google Scholar
• Veljovich D S, Paley P J, Drescher C W, Everett E N, Shah C, Peters W A. Robotic surgery in gynecologic oncology: program initiation and outcomes after the first year with comparison with laparotomy for endometrial cancer staging. Am J Obstet Gynecol 2008; 198: 679.e1–679.e9
   Google Scholar
• Boggess J F, Gehrig P A, Cantrell L, Shafer A, Ridgway M, Skinner E N, Fowler W C. A comparative study of 3 surgical methods for hysterectomy with staging for endometrial cancer: robotic assistance, laparoscopy, laparotomy. Am J Obstet Gynecol 2008; 199: 360.e1–360.e9
   Web of Science ®Google Scholar
• Malzoni M, Tinelli R, Cosentino F, Perone C, Rasile M, Iuzzolino D, Malzoni C, Reich H. Total laparoscopic hysterectomy versus abdominal hysterectomy with lymphadenectomy for early-stage endometrial cancer: a prospective randomized study. Gynecol Oncol 2009; 112: 126–133
   PubMed Web of Science ®Google Scholar
• Kurman R J, Norris H J. Evaluation of criteria for distinguishing atypical endometrial hyperplasia from well-differentiated carcinoma. Cancer 1982; 49: 2547–2559
   PubMed Web of Science ®Google Scholar
• Edris F, Vilos G A, Al-Mubarak A, Ettler H C, Hollett-Caines J, Abu-Rafea B. Resectoscopic surgery may be an alternative to hysterectomy in high-risk women with atypical endometrial hyperplasia. J Minim Invasive Gynecol 2007; 14: 68–73
   Google Scholar
• Kurman R J, Kaminski P F, Norris H J. The behaviour of endometrial hyperplasia: a long term study of untreated hyperplasia in 170 patients. Cancer 1985; 56: 403–412
   PubMed Web of Science ®Google Scholar
• Kim Y B, Holschneider C H, Ghosh K, Nieberg R K, Montz F J. Progestin alone as primary treatment of endometrial carcinoma in premenopausal women. Report of seven cases and review of the literature. Cancer 1997; 15(79)320–327
   Google Scholar
• Agorastos T, Bontis J, Vakiani A, Vavilis D, Constantinidis T. Treatment of endometrial hyperplasias with gonadotropin-releasing hormone agonists: pathological, clinical, morphometric, and DNA-cytometric data. Gynecol Oncol 1997; 65: 102–114
   PubMedGoogle Scholar
• Kung F T, Chen W J, Chou H H, Ko S F, Chang S Y. Conservative management of early endometrial adenocarcinoma with repeat curettage and hormone therapy under assistance of hysteroscopy and laparoscopy. Hum Reprod 1997; 12: 1649–1653
   Google Scholar
• Randall T C, Kurman R J. Progestin treatment of atypical hyperplasia and well-differentiated carcinoma of the endometrium in women under age 40. Obstet Gynecol 1997; 90: 434–440
   PubMed Web of Science ®Google Scholar
• Emons G, Heyl W. Hormonal treatment of endometrial cancer. J Cancer Res Clin Oncol 2000; 126: 619–623
   PubMed Web of Science ®Google Scholar
• Kaku T, Yoshikawa H, Tsuda H, Sakamoto A, Fukunaga M, Kuwabara Y, Hataeg M, Kodama S, Kuzuya K, Sato S, et al. Conservative therapy for adenocarcinoma and atypical endometrial hyperplasia of the endometrium in young women: central pathologic review and treatment outcome. Cancer Lett 2001; 167: 39–48
   PubMedGoogle Scholar
• Wang C B, Wang C J, Huang H J, Hsueh S, Chou H H, Soong Y K, Lai C H. Fertility-preserving treatment in young patients with endometrial adenocarcinoma. Cancer 2002; 94: 2192–2198
   PubMed Web of Science ®Google Scholar
• Montz F J, Bristow R E, Bovicelli A, Tomacruz R, Kurman R J. Intrauterine progesterone treatment of early endometrial cancer. Am J Obstet Gynecol 2002; 186: 651–657
   PubMed Web of Science ®Google Scholar
• Gotlieb W H, Beiner M E, Shalmon B, Korach Y, Segal Y, Zmira N, Koupolovic J, Ben-Baruch G. Outcome of fertility-sparing treatment with progestins in young patients with endometrial cancer. Obstet Gynecol 2003; 102: 718–725
   PubMed Web of Science ®Google Scholar
• Sparac V, Ujević B, Ujević M, Pagon-Belina Z, Marton U. Successful pregnancy after hysteroscopic removal of grade I endometrial carcinoma in a young woman with Lynch syndrome. Int J Gynecol Cancer 2006; 16(Suppl 1)442–445
   Google Scholar
• Niwa K, Tagami K, Lian Z, Onogi K, Mori H, Tamaya T. Outcome of fertility-preserving treatment in young women with endometrial carcinomas. BJOG 2005; 112: 317–320
   PubMed Web of Science ®Google Scholar
• Lai C H, Huang H J. The role of hormones for the treatment of endometrial hyperplasia and endometrial cancer. Curr Opin Obstet Gynecol 2006; 18: 29–34
   PubMed Web of Science ®Google Scholar
• Yahata T, Fujita K, Aoki Y, Tanaka K. Long-term conservative therapy for endometrial adenocarcinoma in young women. Hum Reprod 2006; 21: 1070–1075
   PubMedGoogle Scholar
• Ushijima K, Yahata H, Yoshikawa H, Konishi I, Yasugi T, Saito T, Nakanishi T, Sasaki H, Saji F, Iwasaka T, et al. Multicenter phase II study of fertility-sparing treatment with medroxyprogesterone acetate for endometrial carcinoma and atypical hyperplasia in young women. J Clin Oncol 2007; 25: 2798–2803
   PubMed Web of Science ®Google Scholar
• Hurst S A, Hartzfeld K M, Del Priore G. Occult myometrial recurrence after progesterone therapy to preserve fertility in a young patient with endometrial cancer. Fertil Steril 2008; 89: 724.e1–724.e3
   Google Scholar
• Chiva L, Lapuente F, González-Cortijo L, Carballo N, García J F, Rojo A, Gonzalez-Martín A. Sparing fertility in young patients with endometrial cancer. Gynecol Oncol 2008; 111(suppl 2)S101–S104
   Google Scholar
• Wu H M, Lai C H, Huang H Y, Wang H S, Soong Y K. A successful live twin birth by in vitro fertilization after conservative treatment of recurrent endometrial cancer. Chang Gung Med J 2008; 31: 102–106
   PubMedGoogle Scholar
• Yamashita Y, Mizutani H, Torashima M, Takahashi M, Miyazaki K, Okamura H, Ushijima H, Ohtake H, Tokunaga T. Assessment of myometrial invasion by endometrial carcinoma: transvaginal sonography vs. contrast-enhanced MR imaging. AJR Am J Roentgenol 1993; 161: 595–599
   PubMed Web of Science ®Google Scholar
• Kim S H, Kim H D, Song Y S, Kang S B, Lee H B. Detection of deep myometrial invasion in endometrial carcinoma: comparison of transvaginal ultrasound, CT, and MRI. J Comput Assist Tomogr 1995; 19: 766–772
   PubMed Web of Science ®Google Scholar
• Nagar H, Dobbs S, McClelland H R, Price J, McCluggage W G, Grey A. The diagnostic accuracy of magnetic resonance imaging in detecting cervical involvement in endometrial cancer. Gynecol Oncol 2006; 103: 431–434
   PubMed Web of Science ®Google Scholar
• Rockall A G, Meroni R, Sohaib S A, Reynolds K, Alexander-Sefre F, Shepherd J H, Jacobs I, Reznek R H. A evaluation of endometrial carcinoma on magnetic resonance imaging. Int J Gynecol Cancer 2007; 17: 188–196
   PubMed Web of Science ®Google Scholar
• Vasconcelos C, Félix A, Cunha T M. Preoperative assessment of deep myometrial and cervical invasion in endometrial carcinoma: comparison of magnetic resonance imaging and histopathologic evaluation. J Obstet Gynaecol 2007; 27: 65–70
   Google Scholar
• Connor J P, Andrews J I, Anderson B, Buller R E. Computed tomography in endometrial carcinoma. Obstet Gynecol 2000; 95: 692–696
   PubMed Web of Science ®Google Scholar
• Zerbe M J, Bristow R, Grumbine F C, Montz F J. Inability of preoperative computed tomography scans to accurately predict the extent of myometrial invasion and extracorporal spread in endometrial cancer. Gynecol Oncol 2000; 78: 67–70
   PubMed Web of Science ®Google Scholar
• Horowitz N S, Dehdashti F, Herzog T J, Rader J S, Powell M A, Gibb R K, Grigsby P W, Siegel B A, Mutch D G. Prospective evaluation of FDG-PET for detecting pelvic and para-aortic lymph node metastasis in uterine corpus cancer. Gynecol Oncol 2004; 95: 546–551
   PubMed Web of Science ®Google Scholar
• Creasman W T, Morrow C P, Bundy B N, Homesley H D, Graham J E, Heller P B. Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study. Cancer 1987; 60: 2035–2041
   PubMed Web of Science ®Google Scholar
• Gitsch G, Hanzal E, Jensen D, Hacker N F. Endometrial cancer in premenopausal women 45 years and younger. Obstet Gynecol 1995; 85: 504–508
   PubMed Web of Science ®Google Scholar
• Duska L R, Garrett A, Rueda B R, Haas J, Chang Y, Fuller A F. Endometrial cancer in women 40 years old or younger. Gynecol Oncol 2001; 83: 388–393
   PubMed Web of Science ®Google Scholar
• Walsh C, Holschneider C, Hoang Y, Tieu K, Karlan B, Cass I. Coexisting ovarian malignancy in young women with endometrial cancer. Obstet Gynecol 2005; 106: 693–699
   PubMed Web of Science ®Google Scholar
• Shamshirsaz A A, Withiam-Leitch M, Odunsi K, Baker T, Frederick P J, Lele S. Young patients with endometrial carcinoma selected for conservative treatment: a need for vigilance for synchronous ovarian carcinomas, case report and literature review. Gynecol Oncol 2007; 104: 757–760
   PubMed Web of Science ®Google Scholar
• Morice P, Fourchotte V, Sideris L, Gariel C, Duvillard P, Castaigne D. A need for laparoscopic evaluation of patients with endometrial carcinoma selected for conservative treatment. Gynecol Oncol 2005; 96: 245–248
   PubMed Web of Science ®Google Scholar
• Corrado G, Ercoli A, Ferrandina G, Scambia G. Re: a need for laparoscopic evaluation of patients with endometrial carcinoma selected for conservative treatment by P. Morice et al. Gynecol Oncol 2005; 98: 175, author reply 176
   PubMed Web of Science ®Google Scholar
• Gadducci A, Genazzani A R. Steroid hormones in endometrial and breast cancer. Review. Eur J Gynaecol Oncol 1997; 18: 371–378
   PubMed Web of Science ®Google Scholar
• Gadducci A, Genazzani A R. Endocrine therapy for gynecological cancer. Gynecol Endocrinol 1999; 13: 441–456
   PubMed Web of Science ®Google Scholar
• Saegusa M, Okayasu I. Progesterone therapy for endometrial carcinoma reduces cell proliferation but does not alter apoptosis. Cancer 1998; 83: 111–121
   PubMedGoogle Scholar
• Lovely L P, Fazleabas A T, Fritz M A, McAdams D G, Lessey B A. Prevention of endometrial apoptosis: randomized prospective comparison of human chorionic gonadotropin versus progesterone treatment in the luteal phase. J Clin Endocrinol Metab 2005; 90: 2351–2356
   Google Scholar
• Bese T, Vural A, Ozturk M, Dagistanli F, Demirkiran F, Tuncdemir M, Arvas M, Sanioglu C, Kosebay D. The effect of long-term use of progesterone therapy on proliferation and apoptosis in simple endometrial hyperplasia without atypia. Int J Gynecol Cancer 2006; 16: 809–813
   PubMedGoogle Scholar
• Narkar M, Kholkute S, Chitlange S, Nandedkar T. Expression of steroid hormone receptors, proliferation and apoptotic markers in primate endometrium. Mol Cell Endocrinol 2006; 246: 107–113
   Google Scholar
• Guzeloglu-Kayisli O, Kayisli U A, Al-Rejjal R, Zheng W, Luleci G, Arici A. Regulation of PTEN (phosphatase and tensin homolog deleted on chromosome 10) expression by estradiol and progesterone in human endometrium. J Clin Endocrinol Metab 2003; 88: 5017–5026
   PubMed Web of Science ®Google Scholar
• Minaguchi T, Nakagawa S, Takazawa Y, Nei T, Horie K, Fujiwara T, Osuga Y, Yasugi T, Kugu K, Yano T, et al. Combined phospho-Akt and PTEN expressions associated with post-treatment hysterectomy after conservative progestin therapy in complex atypical hyperplasia and stage Ia, G1 adenocarcinoma of the endometrium. Cancer Lett 2007; 248: 112–122
   Google Scholar
• Kauppila A. Progestin therapy of endometrial, breast and ovarian carcinoma. A review of clinical observation. Acta Obstet Gynecol Scand 1984; 63: 441–450
   PubMed Web of Science ®Google Scholar
• Piver M S, Barlow J J, Lurain J R, Blumenson L E. Medroxyprogesterone acetate (Depo-Provera) vs. hydroxyprogesterone caproate (Delalutin) in women with metastatic endometrial adenocarcinoma. Cancer 1980; 45: 268–272
   PubMed Web of Science ®Google Scholar
• Podratz K C, O'Brien P C, Malkasian G D, Jr, Decker D G, Jefferies J A, Edmonson J H. Effects of progestational agents in treatment of endometrial carcinoma. Obstet Gynecol 1985; 66: 106–110
   PubMed Web of Science ®Google Scholar
• Thigpen J T, Brady M F, Alvarez R D, Adelson M D, Homesley H D, Manetta A, Soper J T, Given F T. Oral medroxyprogesterone acetate in the treatment of advanced or recurrent endometrial carcinoma: a dose-response study by the Gynecologic Oncology Group. J Clin Oncol 1999; 17: 1736–1744
   PubMed Web of Science ®Google Scholar
• Markman M. Hormonal therapy of endometrial cancer. Eur J Cancer 2005; 41: 673–675
   PubMed Web of Science ®Google Scholar
• Gadducci A, Cosio S, Genazzani A R. Old and new perspectives in the pharmacological treatment of advanced or recurrent endometrial cancer: hormonal therapy, chemotherapy and molecularly targeted therapies. Crit Rev Oncol Hematol 2006; 58: 242–256
   PubMed Web of Science ®Google Scholar
• Yasuda M, Matsui N, Kajiwara H, Osamura R Y, Miyamoto T, Murakami M, Shinozuka T, Itoh J. Malignant transformation of atypical endometrial hyperplasia after progesterone therapy showing germ-cell tumor-like differentiation. Pathol Int 2004; 54: 451–456
   Google Scholar
• Ferrandina G, Zannoni G F, Gallotta V, Foti E, Mancuso S, Scambia G. Progression of conservatively treated endometrial carcinoma after full term pregnancy: a case report. Gynecol Oncol 2005; 99: 215–217
   Google Scholar
• Cormio G, Martino R, Loizzi V, Resta L, Selvaggi L. A rare case of choroidal metastasis presented after conservative management of endometrial cancer. Int J Gynecol Cancer 2006; 16: 2044–2048
   Google Scholar
• Le Digabel J F, Gariel C, Catala L, Dhainaut C, Madelenat P, Descamps P. Young women with atypical endometrial hyperplasia or endometrial adenocarcinoma stage I: will conservative treatment allow pregnancy? Results of a French multicentric survey]. Gynecol Oncol Fertil 2006; 34: 27–33
   Google Scholar
• Yamazawa K, Hirai M, Fujito A, Nishi H, Terauchi F, Ishikura H, Shozu M, Isaka K. Fertility-preserving treatment with progestin, and pathological criteria to predict responses, in young women with endometrial cancer. Hum Reprod 2007; 22: 1953–1958
   PubMed Web of Science ®Google Scholar
• Corrado G, Baiocco E, Carosi M, Vizza E. Progression of conservatively treated endometrial complex atypical hyperplasia in a young woman: a case report. Fertil Steril 2008; 90: 2006.e5–2006.e8
   Web of Science ®Google Scholar
• Kothari R, Seamon L, Cohn D, Fowler J, O'Malley D M. Stage IV endometrial cancer after failed conservative management: a case report. Gynecol Oncol 2008; 111: 579–582
   PubMedGoogle Scholar
• Dhar K K, NeedhiRajan T, Koslowski M, Woolas R P. Is levonorgestrel intrauterine system effective for treatment of early endometrial cancer? Report of four cases and review of the literature. Gynecol Oncol 2005; 97: 924–927
   PubMed Web of Science ®Google Scholar
• Giannopoulos T, Butler-Manuel S, Tailor A. Levonorgestrel-releasing intrauterine system (LNG-IUS) as a therapy for endometrial carcinoma. Gynecol Oncol 2004; 95: 762–764
   PubMed Web of Science ®Google Scholar
• Covens A, Thomas G, Shaw P, Ackerman I, Osborne R, Lukka H, Carey M, Franssen E, Roche K. A phase II study of leuprolide in advanced/ recurrent endometrial cancer. Gynecol Oncol 1997; 64: 126–129
   PubMed Web of Science ®Google Scholar
• Lhommé C, Vennin P, Callet N, Lesimple T, Achard J L, Chauvergne J, Luporsi E, Chinet-Charrot P, Coudert B, Couette J E, et al. A multicenter phase II study with triptorelin (sustained-release LHRH agonist) in advanced or recurrent endometrial carcinoma: a French anticancer federation study. Gynecol Oncol 1999; 75: 187–193
   PubMed Web of Science ®Google Scholar
• Asbury R F, Brunetto V L, Lee R B, Reid G, Rocereto T F. Goserelin acetate as treatment for recurrent endometrial carcinoma: a Gynecologic Oncology Group study. Am J Clin Oncol 2002; 25: 557–560
   PubMed Web of Science ®Google Scholar
• Orbo A, Nilsen M N, Arnes M S, Pettersen I, Larsen K. Loss of expression of MLH1, MSH2, MSH6, and PTEN related to endometrial cancer in 68 patients with endometrial hyperplasia. Int J Gynecol Pathol 2003; 22: 141–148
   Google Scholar
• Rubatt J M, Slomovitz B M, Burke T W, Broaddus R R. Development of metastatic endometrial endometrioid adenocarcinoma while on progestin therapy for endometrial hyperplasia. Gynecol Oncol 2005; 99: 472–476
   Google Scholar
• Kimmig R, Strowitzki T, Muller-Hocker J, Kurzl R, Korell M, Hepp H. Conservative treatment of endometrial cancer permitting subsequent triplet pregnancy. Gynecol Oncol 1995; 58: 255–257
   Google Scholar
• Shibahara H, Shigeta M, Toji H, Wakimoto E, Adachi S, Ogasawara T, Takemura T, Koyama K. Successful pregnancy in an infertile patient with conservatively treated endometrial adenocarcinoma after transfer of embryos obtained by intracytoplasmic sperm injection. Hum Reprod 1999; 14: 1908–1911
   PubMed Web of Science ®Google Scholar
• Mitsushita J, Toki T, Kato K, Fujii S, Konishi I. Endometrial carcinoma remaining after term pregnancy following conservative treatment with medroxyprogesterone acetate. Gynecol Oncol 2000; 79: 129–132
   PubMed Web of Science ®Google Scholar
• Jobo T, Imai M, Kawaguchi M, Kenmochi M, Kuramoto H. Successful conservative treatment of endometrial carcinoma permitting subsequent pregnancy: report of two cases. Eur J Gynaecol Oncol 2000; 21: 119–122
   PubMed Web of Science ®Google Scholar
• Ogawa S, Koike T, Shibahara H, Ohwada M, Suzuki M, Araki S, Sato I. Assisted reproductive technologies in conjunction with conservatively treated endometrial adenocarcinoma. A case report. Gynecol Oncol Invest 2001; 51: 214–246
   Google Scholar
• Pinto A B, Gopal M, Herzog T J, Pfeifer J D, Williams D B. Successful in vitro fertilization pregnancy after conservative management of endometrial cancer. Fertil Steril 2001; 76: 826–829
   PubMed Web of Science ®Google Scholar
• Lowe M P, Cooper B C, Sood A K, Davis W A, Syrop C H, Sorosky J I. Implementation of assisted reproductive technologies following conservative management of FIGO grade I endometrial adenocarcinoma and/or complex hyperplasia with atypia. Gynecol Oncol 2003; 91: 569–572
   PubMed Web of Science ®Google Scholar
• Yarali H, Bozdag G, Aksu T, Ayhan A. A successful pregnancy after intracytoplasmic sperm injection and embryo transfer in a patient with endometrial cancer who was treated conservatively. Fertil Steril 2004; 81: 214–216
   PubMed Web of Science ®Google Scholar
• Nakao Y, Nomiyama M, Kojima K, Matsumoto Y, Yamasaki F, Iwasaka T. Successful pregnancies in 2 infertile patients with endometrial adenocarcinoma. Gynecol Obstet Invest 2004; 58: 68–71
   Google Scholar
• Demirol A, Bahce M, Ayhan A, Gurgan T. Pregnancy following intracytoplasmic sperm injection and preimplantation genetic diagnosis after the conservative management of endometrial cancer. Reprod Biomed Online 2005; 10: 770–773
   Google Scholar
• Piura B. Two successful pregnancies after in vitro fertilization and embryo transfer in a patient with endometrial atypical hyperplasia bordering on adenocarcinoma treated conservatively with high-dose progesterone. Gynecol Obstet Invest 2006; 61: 21–23
   Google Scholar
• Park J C, Cho C H, Rhee J H. A successful live birth through in vitro fertilization program after conservative treatment of FIGO grade I endometrial cancer. J Korean Med Sci 2006; 21: 567–571
   PubMed Web of Science ®Google Scholar
• Elizur S E, Beiner M E, Korach J, Weiser A, Ben-Baruch G, Dor J. Outcome of in vitro fertilization treatment in infertile women conservatively treated for endometrial adenocarcinoma. Fertil Steril 2007; 88: 1562–1567
   PubMedGoogle Scholar
• Plante M. Fertility preservation in the management of gynecologic cancers. Curr Opin Oncol 2000; 12: 497–507
   PubMed Web of Science ®Google Scholar
• Seli E, Tangir J. Fertility preservation options for female patients with malignancies. Curr Opin Obstet Gynecol 2005; 17: 299–308
   PubMed Web of Science ®Google Scholar
• Kesic V. Fertility after the treatment of gynecologic tumors. Recent Results Cancer Res 2008; 178: 79–95
   Google Scholar